Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD

被引：3
|
作者：
Naguy, Ahmed [1 ]
机构：
[1] KCMH, Al Manara CAP Ctr, Shuwaikh, State Of Kuwait, Kuwait
来源：
JOURNAL OF NERVOUS AND MENTAL DISEASE | 2017年 / 205卷 / 09期
关键词：
PERVASIVE DEVELOPMENTAL DISORDERS; AUTISM SPECTRUM DISORDERS; CHILDREN; ATOMOXETINE;
D O I：
10.1097/NMD.0000000000000723
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：738 / 738
页数：1
相关论文
共 50 条
  • [21] An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
    Wilens, Timothy E.
    Morrison, Nicholas R.
    Prince, Jefferson
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (10) : 1443 - 1465
  • [22] Pharmacotherapy for Child and Adolescent Attention-deficit Hyperactivity Disorder
    Kaplan, Gabriel
    Newcorn, Jeffrey H.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (01) : 99 - +
  • [23] Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder
    Ozbaran, Burcu
    Kose, Sezen
    Yuzuguldu, Onur
    Atar, Burcu
    Aydin, Cahide
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2015, 16 (08): : 619 - 624
  • [24] Medication in attention deficit hyperactivity disorder and adhd with Autistic Spectrum Disorder (ASD)
    Bohane, L.
    Young, M.
    Rowlandson, P.
    WCPCG 2010, 2010, 5 : 655 - 659
  • [25] Pharmacotherapy of Attention-Deficit/ Hyperactivity Disorder in Individuals with Autism Spectrum Disorder
    Joshi, Gagan
    Wilens, Timothy E.
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2022, 31 (03) : 449 - 468
  • [26] Pharmacotherapy of Attention-Deficit/Hyperactivity disorder (ADHD) and comorbid disorders
    Wiesegger, Georg
    Kienbacher, Christian
    Pellegrini, Elisabeth
    Scheidinger, Hans
    Vesely, Christine
    Und, Waltraud BangerJ
    Friedrich, Max
    NEUROPSYCHIATRIE, 2007, 21 (03) : 187 - 206
  • [27] Attention-Deficit Hyperactivity Disorder Recent Advances in Paediatric Pharmacotherapy
    May, Diane E.
    Kratochvil, Christopher J.
    DRUGS, 2010, 70 (01) : 15 - 40
  • [28] Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
    Michael J. Minzenberg
    Neurotherapeutics, 2012, 9 : 610 - 621
  • [29] Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
    Garland, EJ
    JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (04) : 385 - 395
  • [30] Pharmacotherapy of attention-deficit hyperactivity disorder in private health insurance
    Wild, Frank
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (02): : 84 - +
12345